Bromocriptine in peripartum cardiomyopathy: A meta-analysis with trial sequential analysis [0.03%]
围产期心肌病使用溴隐亭的疗效和安全性：系统评价和meta分析
Umar G Adamu,Kabo Mojela,Kamilu M Karaye et al.
Umar G Adamu et al.
Bromocriptine has been proposed as a disease-modifying therapy for peripartum cardiomyopathy (PPCM). The long-term outcomes of bromocriptine use remain uncertain. We conducted a systematic review, meta-analysis and trial sequential analysis...
Exercise-induced out-of-proportion increase in afterload and impaired right ventricular contractile reserve in HFpEF [0.03%]
运动诱发的HFpEF患者过度的后负荷增加及右心室收缩储备受损
Jan Sebastian Wolter,Alexander Schulz,Torben Lange et al.
Jan Sebastian Wolter et al.
Aims: The pathophysiology of heart failure with preserved ejection fraction (HFpEF) includes pulmonary vascular remodelling and right ventricular (RV) involvement. We sought to investigate the significance of non-invasive...
Effect of GLP-1 agonist initiation on remotely monitored pulmonary arterial pressures in patients with heart failure [0.03%]
心力衰竭患者启动GLP-1激动剂对远程监测肺动脉压的影响
Ana Lanier,Fiona Lutolli,Mark N Belkin
Ana Lanier
Impact of early intensive GDMT on LVEF recovery and ICD decision making in de novo HFrEF [0.03%]
早期强化GDMT对初始HFpEF患者LVEF恢复及ICD决策的影响
Diogo Rosa Ferreira,Daniel Inácio Cazeiro,Joana Brito et al.
Diogo Rosa Ferreira et al.
Aims: Implantable cardioverter-defibrillator (ICD) implantation is recommended in patients with heart failure with reduced ejection fraction (HFrEF) and left ventricular ejection fraction (LVEF) ≤ 35% after 3 months of o...
Gastroesophageal reflux disease and risk of atrial fibrillation/flutter: Implications for heart failure progression [0.03%]
胃食管反流病与心房颤动风险的关系：对心脏衰竭恶化的启示
Wansong Hu,Yingxing Wu,Wanqian Yu et al.
Wansong Hu et al.
Aims: While observational studies suggest an association between gastroesophageal reflux disease (GERD) and atrial fibrillation/flutter (AF/AFL), the causal relationship and mechanisms remain undefined. This study employe...
Impact of standardized team-based care on cardiogenic shock outcomes over time [0.03%]
基于团队的标准护理对心源性休克的影响及其随时间的变化趋势
Behnam N Tehrani,Carolyn M Rosner,Adetokunbo Fadahunsi et al.
Behnam N Tehrani et al.
Background and aims: Limited data exist regarding the impact of standardized care on cardiogenic shock (CS) outcomes over time. We aimed to investigate the influence of multidisciplinary management on CS outcomes followin...
Arrhythmogenic cardiomyopathy mimicking cardiac amyloidosis with Waldenström macroglobulinaemia: A diagnostic challenge [0.03%]
以华氏巨球蛋白血症伴心肌淀粉样变型伪装的致心律失常性右室心肌病--一项诊断挑战
Lianyue Ma,Lin Chen,Jiaqi Li et al.
Lianyue Ma et al.
Case Reports
ESC heart failure. 2025 Nov 3. DOI:10.1002/ehf2.15447 2025
Advancing cardio-obstetric care through digital health technologies: A narrative review [0.03%]
通过数字健康技术推进心血管妊娠护理：叙述性回顾
Toluwalase Awoyemi,Oluwaremilekun Zeth Tolu-Akinnawo,Arun Mahtani et al.
Toluwalase Awoyemi et al.
Cardiovascular disease is a leading cause of maternal morbidity and mortality. As cardio-obstetric care evolves, digital health technologies including telehealth, wearable devices and remote monitoring are playing an increasingly critical r...
Cardioimmunologic response patterns after an acute heart failure event: Design and first results of AHF-ImmunoCS [0.03%]
急性心力衰竭事件后的心血管免疫反应模式：AHF-ImmunoCS研究设计及初步结果
Niklas Beyersdorf,Boshra Afshar,Dora Pelin et al.
Niklas Beyersdorf et al.
Aims: We have previously shown that patients who develop heart-reactive antibodies (HRAs) de novo after a heart failure (HF) hospitalization are at increased risk of adverse outcomes, lending weight to the hypothesis that...
The utility of urine biomarkers in diuretic resistance prediction in heart failure hospitalization [0.03%]
利尿剂抵抗的尿液生物标志物预测价值用于住院心力衰竭患者
Tomasz Imiela,Piotr Poplawski,Beata Zaborska et al.
Tomasz Imiela et al.
Aims: Loop diuretic resistance (LDR) in patients with heart failure hospitalization (HHF) is associated with worse clinical outcomes. The study aimed to assess the predictive ability of urine biomarkers for LDR in HHF. ...